An Innovative Disease‐Drug‐Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate

As with other psychiatric disorders, development of drugs to treat binge‐eating disorder (BED) has been hampered by high placebo response and dropout rates in randomized controlled trials (RCTs). Although not approved for use in BED, several RCTs have suggested that topiramate is efficacious for BED...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalaria, Shamir N., McElroy, Susan L., Gobburu, Jogarao, Gopalakrishnan, Mathangi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951469/
https://www.ncbi.nlm.nih.gov/pubmed/31386273
http://dx.doi.org/10.1111/cts.12682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951469/
https://www.ncbi.nlm.nih.gov/pubmed/31386273
http://dx.doi.org/10.1111/cts.12682

Ejemplares similares